FibroBiologics, Inc. (FBLG)
0.95
-0.07
(-6.86%)
USD |
NASDAQ |
Oct 23, 16:00
0.9643
+0.01
(+1.51%)
Pre-Market: 20:00
FibroBiologics Total Assets (Quarterly) : 7.929M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.929M |
| March 31, 2026 | 5.938M |
| December 31, 2025 | 19.36M |
| September 30, 2025 | 8.744M |
| June 30, 2025 | 13.91M |
| March 31, 2025 | 11.43M |
| December 31, 2024 | 22.12M |
| September 30, 2024 | 10.47M |
| Date | Value |
|---|---|
| June 30, 2024 | 8.912M |
| March 31, 2024 | 11.40M |
| December 31, 2023 | 11.82M |
| September 30, 2023 | 13.30M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 4.824M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.293M |
| Shareholders Equity (Quarterly) | 4.636M |
| Debt to Equity Ratio | 0.3154 |
| Current Ratio | 2.644 |
| Net Debt Paydown Yield | 19.62% |